Helen F. Oates

525 total citations
27 papers, 418 citations indexed

About

Helen F. Oates is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Helen F. Oates has authored 27 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Helen F. Oates's work include Receptor Mechanisms and Signaling (11 papers), Renin-Angiotensin System Studies (9 papers) and Neuroscience and Neuropharmacology Research (4 papers). Helen F. Oates is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Renin-Angiotensin System Studies (9 papers) and Neuroscience and Neuropharmacology Research (4 papers). Helen F. Oates collaborates with scholars based in Australia and United States. Helen F. Oates's co-authors include Gordon S. Stokes, Robert M. Graham, Ruth M. Graham, B. G. Storey and M. A. Weber and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Pharmacology and Experimental Therapeutics and American Heart Journal.

In The Last Decade

Helen F. Oates

26 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen F. Oates Australia 10 179 151 74 57 56 27 418
Nicolas D. Vlachakis United States 14 182 1.0× 78 0.5× 86 1.2× 63 1.1× 42 0.8× 35 494
Louis Wj Australia 14 150 0.8× 133 0.9× 74 1.0× 76 1.3× 62 1.1× 29 547
BN Prichard United Kingdom 12 150 0.8× 69 0.5× 47 0.6× 59 1.0× 34 0.6× 17 380
V. Carson Australia 13 285 1.6× 115 0.8× 29 0.4× 70 1.2× 76 1.4× 21 483
Bert K.B. Lum United States 11 167 0.9× 148 1.0× 20 0.3× 72 1.3× 71 1.3× 21 413
R. W. Sevy United States 11 145 0.8× 59 0.4× 59 0.8× 50 0.9× 21 0.4× 34 396
Robert J. Laffan Malaysia 10 338 1.9× 390 2.6× 81 1.1× 84 1.5× 133 2.4× 16 717
Herman B. Daniell United States 9 143 0.8× 88 0.6× 18 0.2× 40 0.7× 50 0.9× 15 414
J. S. Stephenson United Kingdom 6 140 0.8× 132 0.9× 22 0.3× 52 0.9× 57 1.0× 8 463
WH Aellig Japan 9 202 1.1× 66 0.4× 65 0.9× 114 2.0× 30 0.5× 10 452

Countries citing papers authored by Helen F. Oates

Since Specialization
Citations

This map shows the geographic impact of Helen F. Oates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen F. Oates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen F. Oates more than expected).

Fields of papers citing papers by Helen F. Oates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen F. Oates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen F. Oates. The network helps show where Helen F. Oates may publish in the future.

Co-authorship network of co-authors of Helen F. Oates

This figure shows the co-authorship network connecting the top 25 collaborators of Helen F. Oates. A scholar is included among the top collaborators of Helen F. Oates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen F. Oates. Helen F. Oates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oates, Helen F., et al.. (1981). STUDIES IN THE RAT ON ENDRALAZINE, A NEW ANTIHYPERTENSIVE DRUG STRUCTURALLY RELATED TO HYDRALAZINE. Clinical and Experimental Pharmacology and Physiology. 8(2). 133–139. 5 indexed citations
2.
Oates, Helen F.. (1980). PARTICIPATION OF β2 ADRENOCEPTORS IN THE HYPOTENSIVE RESPONSES TO PHENTOLAMINE OR PRAZOSIN IN THE RAT. Clinical and Experimental Pharmacology and Physiology. 7(6). 695–698. 2 indexed citations
3.
Stokes, Gordon S., et al.. (1980). Antihypertensive therapy: New pharmacological approaches. American Heart Journal. 100(5). 741–752. 4 indexed citations
4.
Oates, Helen F.. (1980). NEW ANTIHYPERTENSIVE AGENT (BUCINDOLOL). The Medical Journal of Australia. 2(4). 224–225. 1 indexed citations
5.
Stokes, Gordon S., et al.. (1980). RESPONSIVENESS OF HYPERTENSIVE SUBJECTS TO PRAZOSIN. Clinical and Experimental Pharmacology and Physiology. 7(2). 215–217. 7 indexed citations
6.
Oates, Helen F., et al.. (1980). HAEMODYNAMIC INTERACTIONS BETWEEN α‐ AND β‐ADRENO‐CEPTOR ANTAGONISTS IN CONSCIOUS OR ANAESTHETIZED RATS. Clinical and Experimental Pharmacology and Physiology. 7(2). 231–236. 2 indexed citations
7.
Oates, Helen F., et al.. (1979). EFFECTS OF PRAZOSIN ON BLOOD PRESSURE AND PLASMA RENIN ACTIVITY DURING ONSET AND WITHDRAWAL OF ACTION IN THE ANAESTHETIZED RAT. Clinical and Experimental Pharmacology and Physiology. 6(3). 355–358. 3 indexed citations
8.
Oates, Helen F., et al.. (1979). PROFILE OF A NEW PRAZOSIN CONGENER, BL-5111A. STUDIES IN THE RAT. Clinical and Experimental Pharmacology and Physiology. 7(1). 1–9. 3 indexed citations
9.
Oates, Helen F., et al.. (1978). COMPARATIVE HAEMODYNAMIC EFFECTS OF CLONIDINE ADMINISTERED INTRAMUSCULARLY OR INTRAVENOUSLY TO ANAESTHETIZED RATS. Clinical and Experimental Pharmacology and Physiology. 5(2). 191–193. 1 indexed citations
10.
Oates, Helen F., et al.. (1978). Withdrawal of clonidine: effects of varying dosage or duration of treatment on subsequent blood pressure and heart rate responses.. Journal of Pharmacology and Experimental Therapeutics. 206(2). 268–273. 27 indexed citations
11.
Oates, Helen F., et al.. (1978). INTERACTIONS BETWEEN PRAZOSIN, CLONIDINE AND DIRECT VASODILATORS IN THE ANAESTHETIZED RAT. Clinical and Experimental Pharmacology and Physiology. 5(1). 85–89. 11 indexed citations
12.
Oates, Helen F., Ruth M. Graham, & Gordon S. Stokes. (1977). Mechanism of the hypotensive action of prazosin.. PubMed. 227(1). 41–8. 28 indexed citations
13.
Graham, Robert M., et al.. (1977). Alpha blocking action of the antihypertensive agent, prazosin.. Journal of Pharmacology and Experimental Therapeutics. 201(3). 747–752. 96 indexed citations
14.
Stokes, Gordon S. & Helen F. Oates. (1977). COMMENT 2: COMPARATIVE AND INTERACTION STUDIES WITH PERIPHERALLY ACTING HYPOTENSIVE AGENTS. The Medical Journal of Australia. 2(SP1_Part1). 9–10. 2 indexed citations
15.
Graham, Robert M., et al.. (1976). Prazosin: the first-dose phenomenon.. BMJ. 2(6047). 1293–1294. 109 indexed citations
16.
Oates, Helen F., Gordon S. Stokes, & B. G. Storey. (1975). Plasma renin concentration in hypertension produced by unilateral renal artery constriction in the rat. Clinical and Experimental Pharmacology and Physiology. 2(4). 289–296. 17 indexed citations
17.
Oates, Helen F., et al.. (1974). RENAL HYPERTENSION IN RATS IMMUNIZED AGAINST ANGIOTENSIN I AND ANGIOTENSIN II. The Journal of Experimental Medicine. 139(2). 239–248. 14 indexed citations
18.
Oates, Helen F. & Gordon S. Stokes. (1974). ROLE OF EXTRAPULMONARY CONVERSION IN MEDIATING THE SYSTEMIC PRESSOR ACTIVITY OF ANGIOTENSIN I. The Journal of Experimental Medicine. 140(1). 79–86. 13 indexed citations
19.
Weber, M. A., Helen F. Oates, & Gordon S. Stokes. (1974). Beta-Adrenergic Receptors and Renin Release: Studies with Beta-Adrenoreceptor-Blocking Agents in the Conscious Rabbit. Clinical Science. 48(s2). 89s–91s. 3 indexed citations
20.
Oates, Helen F., et al.. (1974). PLASMA RENIN RESPONSE TO ACUTE BLOCKADE OF ANGIOTENSIN II IN THE ANAESTHETIZED RAT. Clinical and Experimental Pharmacology and Physiology. 1(2). 155–160. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas D. Vlachakis Breakdown of academic impact, for papers by Louis Wj Breakdown of academic impact, for papers by BN Prichard Breakdown of academic impact, for papers by V. Carson Breakdown of academic impact, for papers by Bert K.B. Lum Breakdown of academic impact, for papers by R. W. Sevy Breakdown of academic impact, for papers by Robert J. Laffan Breakdown of academic impact, for papers by Herman B. Daniell Breakdown of academic impact, for papers by J. S. Stephenson Breakdown of academic impact, for papers by WH Aellig
Rankless by CCL
2026